Bazaarvoice, Proto Labs surge in market debuts

Feb 24, 2012 By ALEX VEIGA , AP Business Writer

(AP) -- A splashy Wall Street debut by Bazaarvoice Inc. and Proto Labs Inc. is the latest sign that investor appetite for initial public offerings has rebounded after a dismal IPO market in 2011.

Social commerce site Bazaarvoice and custom parts manufacturer Proto Labs each drew strong demand for their stocks in their first day of trading on Friday.

Proto Labs' shares surged 81 percent from its opening price of $16 to end regular trading at $29.

Shares of Bazaarvoice opened at $12 and climbed 38 percent to $16.51.

IPO watchers say the companies' reflects an improving climate for IPOs this year.

They point to the flirting with 13,000 the past two weeks and say IPOs are being priced lower to lure investors.

Explore further: Jawbone files lawsuit against rival Fitbit

0 shares

Related Stories

LinkedIn's IPO priced at $45 a share

May 18, 2011

(AP) -- LinkedIn priced its IPO at $45 per share to set up the first stock market debut among a fraternity of Internet networking services that's captivating investors.

Zynga plans to raise up to $1.15B in IPO

Dec 02, 2011

(AP) -- Online game maker Zynga says it plans to raise up to $1.15 billion in an initial public offering of 115 million shares in the latest in a spate of Internet IPOs

Jive Software shares soar in public debut

Dec 13, 2011

(AP) -- Shares of Jive Software Inc., which makes Facebook-type social networks for businesses, soared in their public debut Tuesday after the company priced its initial public offering above expectations, raising $161 million.

Fusion-io shares jump in market debut

Jun 09, 2011

(AP) -- Shares of Fusion-io, a maker of fast, chip-based "hard drives" for servers, are climbing in their market debut after the initial public offering priced above expectations.

Internet stock slips raise fears of new bubble

Nov 30, 2011

Quick cooling of hot stock market debuts by Internet darlings such as Groupon has fed fears of another speculative bubble as social networking star Facebook prepares to go public.

Recommended for you

VCs bet big on Silicon Valley biotech

8 hours ago

Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.